Transgene (France) Market Value
| TNG Stock | EUR 1.21 0.07 5.47% |
| Symbol | Transgene |
Transgene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Transgene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Transgene.
| 03/30/2024 |
| 04/29/2024 |
If you would invest 0.00 in Transgene on March 30, 2024 and sell it all today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment in Transgene over 30 days. Transgene is related to or competes with Valneva SE, Abivax SA, DBV Technologies, Innate Pharma, Genfit, Gensight Biologics, and Cellectis. Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for th... More
Transgene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Transgene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Transgene SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.19 | |||
| Value At Risk | (5.19) | |||
| Potential Upside | 4.42 |
Transgene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Transgene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Transgene's standard deviation. In reality, there are many statistical measures that can use Transgene historical prices to predict the future Transgene's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | 0.0879 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Transgene's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Transgene SA Backtested Returns
Transgene SA owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0112, which indicates the firm had a -0.0112% return per unit of risk over the last 3 months. Transgene SA exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Transgene's Variance of 8.67, risk adjusted performance of (0.01), and Coefficient Of Variation of (3,752) to confirm the risk estimate we provide. The entity has a beta of -1.01, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Transgene are expected to decrease slowly. On the other hand, during market turmoil, Transgene is expected to outperform it slightly. Transgene SA has an expected return of -0.0336%. Please make sure to validate Transgene skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Transgene SA performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.84 |
Excellent reverse predictability
Transgene SA has excellent reverse predictability. Overlapping area represents the amount of predictability between Transgene time series from 30th of March 2024 to 14th of April 2024 and 14th of April 2024 to 29th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Transgene SA price movement. The serial correlation of -0.84 indicates that around 84.0% of current Transgene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.84 | |
| Spearman Rank Test | -0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Transgene SA lagged returns against current returns
Autocorrelation, which is Transgene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Transgene's stock expected returns. We can calculate the autocorrelation of Transgene returns to help us make a trade decision. For example, suppose you find that Transgene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Transgene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Transgene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Transgene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Transgene stock over time.
Current vs Lagged Prices |
| Timeline |
Transgene Lagged Returns
When evaluating Transgene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Transgene stock have on its future price. Transgene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Transgene autocorrelation shows the relationship between Transgene stock current value and its past values and can show if there is a momentum factor associated with investing in Transgene SA.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Check out Transgene Correlation, Transgene Volatility and Transgene Alpha and Beta module to complement your research on Transgene. Note that the Transgene SA information on this page should be used as a complementary analysis to other Transgene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Transgene Stock analysis
When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Transgene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.